BG MEDICINE, INC. FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • July 15th, 2015 • BG Medicine, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the “Agreement”) is made as of July 14, 2015, by and among BG Medicine, Inc., a Delaware corporation (the “Company”), and the holders of capital stock of the Company as set forth on Schedule A hereto (the “Stockholders”).
BG MEDICINE, INC. FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT July 14, 2015Securities Purchase Agreement • July 15th, 2015 • BG Medicine, Inc. • In vitro & in vivo diagnostic substances
Reference is hereby made to that certain Securities Purchase Agreement (the “Purchase Agreement”), dated as of May 12, 2015, by and among BG Medicine, Inc. (the “Company”) and the purchasers named therein (the “Purchasers”). Capitalized terms used and not defined herein shall have the meanings given to them in the Purchase Agreement.
